Palovarotene
CAS: 410528-02-8
Ref. 3D-FP167399
| 1mg | Descontinuado | ||
| 2mg | Descontinuado | ||
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado |
Informação sobre produto
Nome:
Palovarotene
Sinónimos:
- 4-[(1E)-2-[5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-3-(1H-pyrazol-1-ylmethyl)-2-naphthalenyl]ethenyl]benzoic acid
- 4-{(1E)-2-[5,5,8,8-tetramethyl-3-(1H-pyrazol-1-ylmethyl)-5,6,7,8-tetrahydronaphthalen-2-yl]ethenyl}benzoicacid
- Benzoic acid, 4-[(1E)-2-[5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-(1H-pyrazol-1-ylmethyl)-2-naphthalenyl]ethenyl]-
- Clm 001
- Ipn 60120
- R 667
- Ro 3300074
- Sohonos
Descrição:
Palovarotene is a retinoid that is used in the treatment of bowel disease. It has been shown to bind to prostacyclin receptor and increase bone mass in the population. Palovarotene inhibits inflammatory bowel disease by inhibiting the production of inflammatory cytokines such as TNF-α, IL-1β, and IL-6. Palovarotene also has been shown to inhibit the activation of osteogenic genes and suppress the growth of autoimmune diseases. This drug has a variety of analogs with different ester linkages that have different pharmaceutical dosages. The symptoms for overdose include nausea, vomiting, hair loss, skin rash, fever, joint pain, and fatigue.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
414.54 g/mol
Fórmula:
C27H30N2O2
Pureza:
Min. 95%
InChI:
InChI=1S/C27H30N2O2/c1-26(2)12-13-27(3,4)24-17-22(18-29-15-5-14-28-29)21(16-23(24)26)11-8-19-6-9-20(10-7-19)25(30)31/h5-11,14-17H,12-13,18H2,1-4H3,(H,30,31)/b11-8+
Chave InChI:
InChIKey=YTFHCXIPDIHOIA-DHZHZOJOSA-N
SMILES:
CC1(C)CCC(C)(C)c2cc(Cn3cccn3)c(/C=C/c3ccc(C(=O)O)cc3)cc21
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
